The expanding field of targeted treatment relies heavily on recombinant growth factor technology, and a precise understanding of individual profiles is essential for optimizing experimental design and therapeutic efficacy. Specifically, examining the attributes of recombinant IL-1A, IL-1B, IL-2, and IL-3 reveals important differences in their struc